THE Department of Health and Aged Care has made amendments to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021.
This is following the issuance of the Therapeutic Goods Serious Scarcity and Substitutable Medicine (Cefaclor) Instrument (SSSI) 2023, which will allow pharmacists to supply different forms of oral cefaclor at equivalent doses for the duration of the shortage, provided specified conditions are met.
Further information about the substitution is available on the PBS Medicine Shortages page.
Learn more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
